Literature DB >> 17239471

A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin.

Kishore B Chalasani1, G J Russell-Jones, Sarath K Yandrapu, Prakash V Diwan, Sanjay K Jain.   

Abstract

In spite of great potential, effective oral delivery of many vitamin B(12)-peptide/protein drug conjugates does not occur due to the limited uptake capacity of the VB(12) transport system, loss of bioactivity of native protein and/or intrinsic factor affinity of VB(12) and liability to GI degradation. In order to overcome these shortcomings in a two pronged way, we have endeavoured to develop a VB(12)-Nanoparticles (NPs) system to enhance the uptake capacity of both NPs and VB(12) transport to deliver orally effective insulin. NPs were prepared using different molecular weight dextrans and epichlorohydrin as cross-linker by an emulsion method. NPs surface was modified with succinic anhydride, and conjugated with amino VB(12) derivatives of carbamate linkage. VB(12) attachment was confirmed by IR, XPS analysis, and was quantified by HPLC (4.0 to 4.4% w/w of NPs). The pre-formed NPs conjugates (Zave=160-250 nm; polydisperse) were loaded with 2, 3 and 4% w/w of insulin, and the entrapment was found to be 45-70%. NPs conjugates were found to protect 65-83% of entrapped insulin against in vitro gut proteases. In vitro release studies exhibit an initial burst followed by diffusion controlled first order kinetics with 75-95% release within 48 h. After oral administration of these carriers (20 IU/kg), a nadir of 70-75% reduction in plasma glucose was found in 5 h, reached basal levels in 8-10 h, and a prolonged second phase was found until 54 h. The % pharmacological availability (PA) of 70 K NPs conjugate containing 2, 3 and 4% w/w insulin was 1.1, 1.9 and 2.6 fold higher, respectively compared to NPs without VB(12); consistent with the hypothesis that uptake was mediated by the vitamin B(12) transport. NPs of 70 K dextran showed 1.4 fold PA compared to 10 K while negligible action was observed with 200 K. The potential utilities of VB(12)-NPs carrier as an oral delivery platform of proteins, especially insulin via dextran-coated particles necessities further elaborate investigations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17239471     DOI: 10.1016/j.jconrel.2006.12.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  28 in total

1.  Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery.

Authors:  Lina Han; Yuefang Zhao; Lifang Yin; Ruiming Li; Yang Liang; Huan Huang; Shirong Pan; Chuanbin Wu; Min Feng
Journal:  AAPS PharmSciTech       Date:  2012-05-30       Impact factor: 3.246

Review 2.  Detecting and treating cancer with nanotechnology.

Authors:  Keith B Hartman; Lon J Wilson; Michael G Rosenblum
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

3.  Trehalose Glycopolymer Enhances Both Solution Stability and Pharmacokinetics of a Therapeutic Protein.

Authors:  Yang Liu; Juneyoung Lee; Kathryn M Mansfield; Jeong Hoon Ko; Sahar Sallam; Chrys Wesdemiotis; Heather D Maynard
Journal:  Bioconjug Chem       Date:  2017-01-03       Impact factor: 4.774

Review 4.  Polymeric nanoparticle drug delivery technologies for oral delivery applications.

Authors:  Eric M Pridgen; Frank Alexis; Omid C Farokhzad
Journal:  Expert Opin Drug Deliv       Date:  2015-03-26       Impact factor: 6.648

Review 5.  Lessons learned from the clinical development of oral peptides.

Authors:  Morten Asser Karsdal; Bente Juul Riis; Nozer Mehta; William Stern; Ehud Arbit; Claus Christiansen; Kim Henriksen
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

6.  Crystal structure of human intrinsic factor: cobalamin complex at 2.6-A resolution.

Authors:  F S Mathews; M M Gordon; Z Chen; K R Rajashankar; S E Ealick; D H Alpers; N Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

7.  Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.

Authors:  Hesham H Salman; Carlos Gamazo; P Chris de Smidt; Gregory Russell-Jones; Juan M Irache
Journal:  Pharm Res       Date:  2008-08-05       Impact factor: 4.200

8.  Assessing the transport of receptor-mediated drug-delivery devices across cellular monolayers.

Authors:  Erik Brewer; Anthony M Lowman
Journal:  J Biomater Sci Polym Ed       Date:  2013-12-24       Impact factor: 3.517

9.  Semi-interpenetrating network (sIPN) co-electrospun gelatin/insulin fiber formulation for transbuccal insulin delivery.

Authors:  Leyuan Xu; Natasha Sheybani; Shunlin Ren; Gary L Bowlin; W Andrew Yeudall; Hu Yang
Journal:  Pharm Res       Date:  2014-07-17       Impact factor: 4.200

10.  Bioavailability of orally administered rhGM-CSF: a single-dose, randomized, open-label, two-period crossover trial.

Authors:  Wenping Zhang; Zhengbing Lv; Zuoming Nie; Guogang Chen; Jian Chen; Qing Sheng; Wei Yu; Yongfeng Jin; Xiangfu Wu; Yaozhou Zhang
Journal:  PLoS One       Date:  2009-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.